← Back to Search

Time-Restricted Eating for Mild Cognitive Impairment

N/A

Recruiting

Led By Julie Pendergast, PhD

Research Sponsored by Julie Pendergast

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 45-95

Postmenopausal Women

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from enrollment to study completion up to approximately 8 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial will study how a time-restricted eating plan affects women with mild memory problems. It may help prevent Alzheimer's, which affects women twice as much as men.

Who is the study for?

This trial is for postmenopausal women aged between 45-95 who have been diagnosed with mild cognitive impairment. It aims to explore a dietary intervention that could potentially improve their condition.

What is being tested?

The study is testing the feasibility of time-restricted eating as an intervention to see if it can help manage or improve mild cognitive impairment in women.

What are the potential side effects?

Since this trial involves a dietary change rather than medication, side effects may include hunger, changes in energy levels, or potential impact on social and daily routines.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 45 and 95 years old.

Select...

I am a woman who has gone through menopause.

Select...

I have been diagnosed with mild memory or thinking problems.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from enrollment to study completion up to approximately 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from enrollment to study completion up to approximately 8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and from enrollment to study completion up to approximately 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Number of participants adhering to TRE protocol

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Time-restricted eatingExperimental Treatment1 Intervention

Participants will have baseline and post-study data collected, including activity/sleep data, metabolic parameters (fasting labs and anthropometric measurements), and cognitive testing. In addition, food timing will be collected throughout the study. Subjects will be educated about the potential health benefits of time-restricted eating and will self-select a 10-hr window, during which all daily calories will be consumed for 8 weeks.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Time-restricted eating

2022

N/A

~850

0 / 3Eligibility criteria met